TLG Capital, a private credit fund manager with a focus on Africa, has officially launched a $2 million senior secured credit line to support an undisclosed company within Uganda’s health sector. This funding, announced on September 1, is designed to help the company expand its operations and improve public access to essential medicines throughout the country.
According to Isaac Marshall, an investor at TLG Capital, this is the firm’s 12th health sector investment in Africa and its 48th overall since its inception. TLG’s history with Uganda dates back to 2009, when it first invested in Quality Chemicals Industries Limited, a Kampala-based manufacturer of life-saving antiretrovirals and antimalarials. This long-standing partnership highlights TLG’s strategy of backing local companies that are critical to enhancing healthcare accessibility in the region.
Isha Doshi, TLG Capital’s chief financial officer, emphasized that this new credit facility aligns with the company’s broader mission of leveraging long-term partnerships to improve public health outcomes. She noted that targeted public and private investments have already contributed to significant improvements in Uganda, including a two-thirds reduction in child mortality and a 60% decrease in AIDS-related deaths since 2009. By focusing on the expansion of pharmaceutical distribution in East Africa, the new credit line aims to build on these successes and further strengthen the country’s health infrastructure.
